VAERS Explorer
Back to explore

Report #2861928

Received Sep 29, 2025

ER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALSUNKC3207—

Symptoms (1)

Urticaria

Symptom narrative

Hives; This non-serious case was reported by a consumer and described the occurrence of hives in a 24-year-old female patient who received HBV (Engerix B) (batch number C3207) for prophylaxis. On an unknown date, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced hives (Verbatim: Hives). The outcome of the hives was not resolved. It was unknown if the reporter considered the hives to be related to Engerix B. It was unknown if the company considered the hives to be related to Engerix B. Additional Information: GSK receipt date: 16-SEP-2025 The seriousness for hives was reported as intervention required. The reporter would like to be contacted to provide the whole story and context of the severity of the reaction.